Calcification of the extracellular matrix (ECM) can be physiological o
r pathological. Physiological calcification occurs in bone when the so
ft ECM is converted into a rigid material capable of sustaining mechan
ical force; pathological calcification can occur in arteries(1) and ca
rtilage(2) and other soft tissues. No molecular determinant regulating
ECM calcification has yet been identified. A candidate molecule is ma
trix GLA protein (Mgp), a mineral-binding ECM protein(3) synthesized b
y vascular smooth-muscle cells and chondrocytes, two cell types that p
roduce an uncalcified ECM, Mice that lack Mgp develop to term but die
within two months as a result of arterial calcification which leads to
blood-vessel rupture. Chondrocytes that elaborate a typical cartilage
matrix can be seen in the affected arteries. Mgp-deficient mice addit
ionally exhibit inappropriate calcification of various cartilages, inc
luding the growth plate, which eventually leads to short stature, oste
openia and fractures. These results indicate that ECM calcification mu
st be actively inhibited in soft tissues. To our knowledge, Mgp is the
first inhibitor of calcification of arteries and cartilage to be char
acterized in vivo.